Background Unfractionated heparin (UFH) is widely used in non-ST-segment elevation myocardial infarction (NSTEMI), but its narrow therapeutic window requires frequent activated partial thromboplastin time (aPTT) monitoring. Data on time in therapeutic range (TTR) in this setting are scarce. Methods We analyzed 1,553 co...
Tal Golani, L. Taha, M. Karmi et al.· Clinical and applied thrombo...· 0 citations
Conventional cardiovascular risk scores estimate the probability of future events; however, these risk scores do not directly quantify the presence or extent of subclinical atherosclerosis. This narrative review critically evaluates the current evidence on the carotid plaque score (CPS), a semiquantitative ultrasound-b...
D. Sulman, S. Cacciatore, Marco Bernardi et al.· Reviews in cardiovascular me...· 0 citations
Systemic inflammation plays a central role in acute cardiovascular diseases. Several routinely available inflammatory biomarkers – including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), C-reactive protein-to-albumin ratio (CAR), fibrinogen-to-...
A. Qadan, Z. Da-don, L. Taha et al.· European Heart Journal· 0 citations
Lipoprotein(a) [Lp(a)] is a genetically determined, apolipoprotein B-containing lipoprotein that contributes to cardiovascular risk through atherogenic, proinflammatory, and potentially antifibrinolytic mechanisms. Genetic, epidemiological, and mechanistic evidence supports a causal role for elevated Lp(a) in atheroscl...
P. Sabouret, Domenico Mario Giamundo, J. Popiołek-Kalisz et al.· Reviews in cardiovascular me...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.